Pharmacy Drugs
Recent Posts
- Malignant Brain Tumors: Chemotherapy Alone Is Just As Effective As Radiation / New Positive Prognostic Factor Found
- Positive Interim Data From Minnow Medical Peripheral Artery Disease Trial Presented At TCT 2009 Conference
- Intercept Pharmaceuticals’ FXR Agonist INT-747 Meets Primary Endpoint In A Phase II Clinical Trial In Type 2 Diabetic Patients
- Largest Clinical Trial To Test Benefits Of Aspirin In Australia
- University Of Florida To Receive $29.5 Million In Recovery Act Funds To Begin Study Of Whether Exercise Prevents Disability In Older Adults
Random Posts
- Pharmacy Union Concerns Unfounded
- Detecting Overall Survival Benefit Derived From Progression-Free Survival In Cancer
- Westminster Kingsway College Launches New Access To Higher Education Programme In Pharmacy And Biomedical Sciences
- Implantable Hearing Aid Gets Nod from FDA Panel
- Eye Drug Trial Marks Milestone For Southampton's Groundbreaking Research Centre, UK
- PUrsuing Novel Stem-Cell Derived Therapy For Lou Gehrig's Disease With $10.8 Million Award
- ImmuPharma Announces Final Results Of PhaseIIb Study Of LUPUZOR™ In Lupus
- Phase III Study Showed Two Years Of ACTEMRA(R) (tocilizumab) Inhibited Progression Of Joint Damage And Improved Disease Remission
- Daily Potassium Citrate Wards Off Kidney Stones In Seizure Patients On High-fat Diet
- Circassia Announces Successful Results From Phase II Clinical Study Of ToleroMune(R) Cat Allergy Therapy
For Development Of Novel Stem Cell Treatments For Heart Attack Patients, Cedars-Sinai Researchers Awarded $5.5 Million
Posted by: admin in Pharmacy Drugs on November 08th, 2009
A team of Cedars-Sinai Heart Institute heart attack patients.
The grant will be used to continue Marbán’s development of cardiac stem cell therapies to strengthen and heal damaged heart muscle caused by cardiac arrest. The grant is part of a new strategy by the California state stem cell agency aimed at speeding the process of moving medical research from the laboratory to patient care.
Generally, it can take a decade or more to develop a new medical treatment to the point of securing federal approval for a clinical trial. The state institute’s Disease Team Research Awards, however, are designed to help researchers develop medical theories into treatments tested by clinical trials in four years or less.
Marbán’s team was one of 11 in California to receive a Disease Team Research Award and is the only team focusing on heart disease. Heart disease is the leading cause of death in the United States. According to the Centers for Disease Control, in 2009, an estimated 785,000 Americans will have a first-time heart attack and about 470,000 will have a recurrent attack.
Earlier this year, Marbán, who is director of the Cedars-Sinai Heart Institute, and his team completed the first procedure in which a patient’s own heart tissue was used to grow specialized heart stem cells that were then injected back into the patient’s heart in an effort to repair and re-grow healthy muscle in a heart that had been injured by a heart attack. The minimally-invasive procedure was completed on the first patient on June 26.
The Disease Team Award will enable Marbán’s team to develop other, new stem cell therapies for heart patients, including a potential treatment for patients with advanced heart failure.
“The support Cedars-Sinai is receiving from the California Institute for Regenerative Medicine will be an important element to succeeding in the fight against heart disease,” Marbán said. “What we work on in our stem cell lab today could translate into tomorrow’s innovative treatment for heart attack patients.”
“We are delighted that Dr. Marbán is receiving CIRM funding to continue his groundbreaking translational science devoted to regenerating diseased myocardial tissue,” said Shlomo Melmed, M.D., Cedars-Sinai Medical Center vice president of academic affairs and dean of the medical faculty. “This award validates the leading role of the Cedars-Sinai Heart Institute in developing cutting-edge treatments for heart disease.”
Source: Sally Stewart
Cedars-Sinai Medical Center
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.